NCT07612930 2026-05-29Expanded Access to PCNAT-01 for Patients With Resected Pancreatic Ductal Adenocarcinoma Following Surgical Resection and Adjuvant TherapyAnda Biopharmaceutical Development (Shenzhen) Co., Ltd.Available